
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Guamuchil fruit (Pithecellobium dulce) contains high concentrations of phenolic compounds, with peel fractions reaching 15.46 mg GAE g⁻¹, that demonstrate potent antioxidant activity through DPPH and ABTS radical scavenging mechanisms. The fruit's bioactive compounds modulate metabolic health by stimulating beneficial gut bacteria like Faecalibacterium prausnitzii to produce butyrate and upregulating PPAR-γ/adiponectin pathways for enhanced insulin sensitivity.

Reported Benefits (Provisional)
Origin & History

Guamuchil (Pithecellobium dulce) is a versatile leguminous tree native to Mexico, Central America, and northern South America. Its pods contain a sweet-tart pulp, traditionally valued for its potent digestive, antimicrobial, and antioxidant properties, making it a significant functional food.
Research Narrative (Provisional)
Multiple studies, including in vitro and animal models, support Guamuchil's potent antioxidant, anti-inflammatory, and antimicrobial properties, attributed to its rich polyphenol and flavonoid content. Research also indicates its potential for improving digestive health, modulating lipid profiles, and supporting cardiovascular function, validating its traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber - Vitamin C - Calcium, Iron, Potassium - Polyphenols, Flavonoids
Reported Mechanism (Provisional)
Phenolic compounds in guamuchil fruit, concentrated primarily in the peel fraction, scavenge DPPH and ABTS radicals while chelating metals to inhibit reactive oxygen species formation. The fruit's bioactive compounds stimulate beneficial bacteria like Faecalibacterium prausnitzii and Ruminococcus species to produce short-chain fatty acids, particularly butyrate. These metabolites upregulate PPAR-γ and adiponectin pathways, enhancing insulin sensitivity while modulating GIP incretin response through delayed gastric emptying.
Clinical Narrative (Provisional)
Human clinical evidence remains extremely limited, with only one documented study examining Pithecellobium dulce fruit flour intake effects on metabolic parameters. This preliminary research demonstrated enhanced short-chain fatty acid production and trends toward attenuated GIP response post-consumption, with insulin sensitivity improvements persisting up to 4 days. The majority of supporting evidence derives from in vitro studies showing antioxidant activity (peel DPPH: 4.13 mg AAE g⁻¹) and cytotoxicity against HeLa cancer cells. Larger randomized controlled trials are critically needed to establish clinical efficacy and safety profiles in humans.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







